FDA authorizes Abbott’s fast $5 Covid-19 test
theverge.com
theverge.com
We really need a test with a high sensitivity rate for presymptomatic and asymptomatic carriers to make a big difference day to day.
Certainly a step in the right direction, but only a step.
50M tests per month is still quite a bit short of where we would need to be for a full reopening, but it's more than twice as much as the rest of our testing combined.